Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.
Press releases published on September 15, 2025
September 15, 2025
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
Indeterminate
GlobeNewswire
September 15, 2025
Extendicare Announces September 2025 Dividend of C$0.042 per Share
Indeterminate
GlobeNewswire
September 15, 2025
Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury
Indeterminate
GlobeNewswire
September 15, 2025
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
Indeterminate
GlobeNewswire
September 15, 2025
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
Indeterminate
GlobeNewswire
September 15, 2025
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
Indeterminate
GlobeNewswire
September 15, 2025
Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial of QTORIN™ Rapamycin for Cutaneous Venous Malformations
Indeterminate
GlobeNewswire
September 15, 2025
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
Indeterminate
GlobeNewswire
September 15, 2025
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
Indeterminate
GlobeNewswire
September 15, 2025
Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer
Indeterminate
GlobeNewswire
September 15, 2025
Harrow Announces Agenda and Speakers for Investor & Analyst Day
Indeterminate
GlobeNewswire
September 15, 2025
Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada
Indeterminate
GlobeNewswire
September 15, 2025
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
Indeterminate
GlobeNewswire
September 15, 2025
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
Indeterminate
GlobeNewswire
September 15, 2025
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
Indeterminate
GlobeNewswire
September 15, 2025
Descartes’ 9th Annual Study Finds Transportation Management Reaches Record Strategic Importance
Indeterminate
GlobeNewswire